Rising GI Disorders Driving the Malabsorption Syndrome Market Worldwide According to a newly published market research report by 24LifeSciences, global malabsorption syndrome market value is at USD 8.5 billion in 2026 and is projected to reach USD 13.2 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.4% during the forecast period. Malabsorption syndrome encompasses a group of disorders where the small intestine is unable to properly absorb sufficient amounts of critical nutrients and fluids from ingested food, leading to deficiencies in macronutrients like proteins, carbohydrates, and fats, as well as vital micronutrients including essential vitamins and minerals. This complex condition, often arising secondary to chronic gastrointestinal diseases, demands a multifaceted therapeutic approach that combines targeted pharmaceuticals with specialized nutritional support, underlining its significant clinical and economic impact on global healthcare systems. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9520/malabsorption-syndrome-market